As shown in the figure, the survival time of patients with low PSMC2 gene expression was longer, while that of patients with high PSMC2 gene expression was shorter (Fig. 4C), indicating that PSMC2 gene expression is also a factor affecting the prognosis of patients with glioma, which is consistent with the above analysis results. Here, PSMC2 is linked to central nervous system cancer.